Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia
RT-CGM was dominant in both insulin-treated subgroups, improving patient outcomes while reducing healthcare costs. These findings highlight the potential value of RT-CGM for broad reimbursement in Australia and the importance of addressing inequities in glycemic management, particularly among Indigenous Australians and younger individuals with T2D.
Authors
- Greg J. Norman (ORCID: https://orcid.org/0000-0003-2899-3238)
- M TUCKER (ORCID: https://orcid.org/0009-0007-4620-8893)
- David S Simmons (ORCID: https://orcid.org/0000-0003-0560-0761)
- Moin Uddin Ahmed (ORCID: https://orcid.org/0000-0002-1733-5216)
- Richard Fulton Pollock (ORCID: https://orcid.org/0000-0002-9873-7507)
- Hamza Alshannaq
- Jéssica Yumi Matuoka (ORCID: https://orcid.org/0000-0002-7956-1606)
Institutions
- Camden and Campbelltown Hospitals (AU)
- The University of Sydney (AU)
- Dexcom (United States) (US)
- NatCen Social Research (GB)
- Covalence Research
- Western Sydney University (AU)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1007/s12325-025-03430-1
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kaiser Permanente